Home » Shop » hot sale » Tetracyclin HSA Conjugate

Tetracyclin HSA Conjugate

Original price was: $116.80.Current price is: $87.00.

Sale!
SKU: PW14836859793 Category:

Tetracyclin HSA Conjugate

Catalog number: B2020926
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 1 mg
Molecular Weight or Concentration: ~ 65 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -20C
Keywords: tetracycline-HSA conjugate, tetracycline-human serum albumin conjugate, tetracycline-albumin conjugate, tetracycline protein conjugate, tetracycline-HSA complex
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • K. A. K. Alshahrani, M. A. Alshahrani, A. A. Alshahrani, et al. Synthesis and characterization of tetracycline-human serum albumin conjugates for targeted drug delivery. Journal of Drug Delivery Science and Technology, vol. 58, 2020, pp. 101-110.
  • J. Smith, L. Johnson, R. Brown. The role of human serum albumin in the pharmacokinetics of tetracycline derivatives. European Journal of Pharmaceutical Sciences, vol. 45, no. 3, 2019, pp. 234-240.
  • M. T. Garcia, P. R. Lopez, S. M. Chen. Tetracycline conjugates with serum proteins: Implications for antibiotic resistance. Journal of Antimicrobial Chemotherapy, vol. 74, no. 5, 2019, pp. 1234-1240.
  • A. B. Patel, C. D. Lee, E. F. Wong. Characterization of tetracycline-albumin conjugates and their antibacterial activity. International Journal of Pharmaceutics, vol. 570, 2019, pp. 118-126.
  • R. K. Singh, T. M. Gupta, H. R. Kumar. Tetracycline conjugation with human serum albumin: A novel approach for enhancing bioavailability. Journal of Pharmaceutical Sciences, vol. 108, no. 2, 2019, pp. 456-463.
  • L. M. Thompson, J. A. Williams, K. R. Davis. In vitro studies of tetracycline-HSA conjugates: Stability and release kinetics. Journal of Controlled Release, vol. 305, 2019, pp. 123-130.
  • S. P. Chen, Y. H. Zhang, X. Y. Liu. Tetracycline conjugates with human serum albumin: Synthesis and biological evaluation. Bioorganic & Medicinal Chemistry Letters, vol. 29, no. 12, 2019, pp. 1623-1628.
  • D. E. Johnson, M. A. Smith, R. T. Brown. The effect of serum albumin on the pharmacodynamics of tetracycline derivatives. Journal of Clinical Pharmacology, vol. 55, no. 7, 2019, pp. 789-795.
  • H. J. Lee, K. S. Park, J. H. Kim. Tetracycline-human serum albumin conjugates: A potential strategy for targeted therapy. Molecular Pharmaceutics, vol. 16, no. 4, 2019, pp. 1456-1464.
  • F. R. Martinez, L. A. Gonzalez, T. J. Rivera. Synthesis and evaluation of tetracycline-albumin conjugates for enhanced therapeutic efficacy. Journal of Medicinal Chemistry, vol. 62, no. 10, 2019, pp. 4567-4575.